Bank of Montreal
LXRX icon

Bank of Montreal’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bank of Montreal’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-25,000
Closed -$157K – 4880
2019
Q2 		$157K Hold
25,000
– – ﹤0.01% 3061
2019
Q1 		$139K Buy
+25,000
New +$152K ﹤0.01% 2917

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Bank of Montreal's LXRX Position: Q2 2026 in Review

Bank of Montreal reduced its Lexicon Pharmaceuticals (LXRX) stake by 43% in Q2 2026, selling an estimated $58.4K and leaving 40,000 shares worth $96K. The position accounts for ﹤0.01% of the portfolio, ranked #3246.

Bank of Montreal first reported a position in LXRX in Q2 2014 and has held it in 36 quarters since. The position peaked at $1.64M in Q4 2016. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • Bank of Montreal held 40,000 shares of Lexicon Pharmaceuticals worth $96K as of Q2 2026.
  • Bank of Montreal sold 30,000 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $58.4K.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #3246 holding.
  • Bank of Montreal first reported a position in Lexicon Pharmaceuticals in Q2 2014 and has held it in 36 quarters since.
  • Bank of Montreal's Lexicon Pharmaceuticals position peaked at $1.64M in Q4 2016.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.